Gyneos® and women’s cognitive aging: what the research shows
Recent scientific coverage highlights Gyneos®, Advenion Nutrition’s standardized D-chiro-inositol ingredient, as a novel nutritional approach for women’s metabolic and cognitive aging. Drawing on preclinical research in female models relevant to cognitive aging, the article explores how Gyneos® may support healthy insulin signaling, help maintain balanced inflammation-related markers, and support cognitive performance — with particular relevance across the menopausal transition.
The article positions Gyneos® — a standardized, traceable source of D-chiro-inositol — as a sex-specific innovation in women’s health, integrating metabolic resilience, hormonal balance, and brain health into a unified approach for healthy aging and long-term cognitive wellbeing. By focusing on the specific Gyneos® ingredient rather than generic D-chiro-inositol, the coverage reinforces the value of standardization and analytical control.
This article summarizes preclinical research and is intended for scientific and product-development audiences. These statements have not been evaluated by the Food and Drug Administration. Gyneos® is an ingredient and is not intended to diagnose, treat, cure, or prevent any disease, including Alzheimer’s disease.